4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001193125-26-396892
Senior VP, Finance and PAO sold 7,842 shares at an average $3.32 ($26,072)
- Senior VP, Finance and PAO bought 509 shares at $3.88 ($1,973)
From the SEC's structured data for this filing
Trades in this filing
Nemec Sarah · Senior VP, Finance and PAO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-05 | Purchase : show line 1 in the form | +509 | $3.88 | $1,973 | 1,924 | D |
| 2026-09-16 | Sale : show line 2 in the form | −843 | $3.77 | $3,181 | 24,081 | D |
| 2026-09-17 | Sale : show line 3 in the form | −2,922 | $3.32 | $9,696 | 21,159 | D |
| 2026-09-18 | Sale : show line 4 in the form | −4,077 | $3.24 | $13,195 | 17,082 | D |
| Open-market purchases · 509 sh · avg $3.88 · $1,973 | ||||||
| Open-market sales · 7,842 sh · avg $3.32 · $26,072 | ||||||
Loading xslF345X06/ownership.xml…